NEW PRODUCT WATCH

RX PHARMACEUTICALSNEW INDICATIONRetrovir (zidovudine) from Burroughs Wellcome, Research Triangle Park, N.C., has been approved by the Food and Drug Administration to prevent HIV-infected pregnant women from transmitting the virus to their babies. Oral dose is one 100-mg capsule or 2 teaspoonfuls (10 mL) syrup every four hours (600 mg total daily dose) during pregnancy and continuous intravenous infusion

RX PHARMACEUTICALS

NEW INDICATION

Retrovir (zidovudine) from Burroughs Wellcome, Research Triangle Park, N.C., has been approved by the Food and Drug Administration to prevent HIV-infected pregnant women from transmitting the virus to their babies. Oral dose is one 100-mg capsule or 2 teaspoonfuls (10 mL) syrup every four hours (600 mg total daily dose) during pregnancy and continuous intravenous infusion during labor.

LEVOXINE CHANGES NAME TO LEVOXYL

Register to view the full article

test - Advanced Registered User

Already a member? .